Andrea L. Cheville, M.D.

The Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial will determine whether systematically assessing patient reported outcomes for sleep disturbance, pain, anxiety, depression, and fatigue among patients with solid and liquid malignancies and using these data to increase the frequency of guideline-concordant care by: 1) reporting these data to their clinical teams, 2) providing patients with needs-matched symptom self-management education, and 3) suggesting evidence-based symptom management strategies to their care teams improves patients' quality of life, symptoms, and adherence to cancer treatment, while reducing their unplanned use of healthcare resources.

The purpose of this study is to create a computerized multidimensional assessment that can quickly assign hospitalized patients to ability-matched rehabilitation care plans, in three essential areas; Mobility, Daily Activity, and Applied Cognition (ability to think/problem solve).

The purpose of this study is an effort to enrich the ongoing NOHARM pragmatic trial. NOHARM AIM 3 will use a mixed methods analysis of patient and care team factors that affect the adoption, implementation and use of the NOHARM intervention using Epic reports, conduct chart reviews and patient interviews, as well as obtain feedback via suveys.

The primary goal of this study is to establish a database of racial/ethnic minority populations who consented to be contacted for biomedical research including clinical trials and bio-specimen research. The database will serve as sampling frames for selecting healthy individuals who initially meet specific study eligibility criteria.

This randomized clinical trial studies collaborative targeted case management in improving functional status in patients with stage III-IV cancer. Collaborative targeted case management may improve functional status and preserve performance in patients with advanced cancer